Guang Chen

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

Thierry Façon, Meletios Α. Dimopoulos, Angela Dispenzieri et al. · Blood · 2017 · 271 citations · Full text

Medicine, Oncology, Hematologic Oncology +9

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 266 citations

Medicine, Internal Medicine, Pathology +17

Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α

Rana K. Gupta, Nan Gao, Regina Gorski et al. · Genes & Development · 2007 · 162 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer

Yansong Lin, Shukui Qin, Zhiyong Li et al. · JAMA Oncology · 2021 · 93 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial

Cyrille Hulin, Andrew R. Belch, Chaim Shustik et al. · Journal of Clinical Oncology · 2016 · 83 citations

Pharmacy, Oncology, Pharmacotherapy +16